{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Organization",
      "@id": "https://tubulis.com/#organization",
      "name": "Tubulis",
      "url": "https://tubulis.com/",
      "description": "Tubulis is now part of Gilead Sciences www.gilead.com NEWS April 21 Tubulis to Present Phase I/IIa Trial Data for ADC Candidate TUB-040 in Platinum-resistant Ovarian Cancer in Rapid Oral Presentation at ASCO 2026 April 07 Gilead to Acquire Tubulis Adding Potentially Best-In-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline January 27 […]"
    },
    {
      "@type": "WebPage",
      "@id": "https://directory.websdocs.com/business/tubulis#asg",
      "name": "Tubulis ASG Directory Profile",
      "url": "https://directory.websdocs.com/business/tubulis",
      "isPartOf": {
        "@id": "https://tubulis.com/#organization"
      },
      "description": "Public business information published by the WebsDocs ASG Directory."
    }
  ]
}